New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...

Alzheimer's disease is at the center of a revolutionary theory in neuroscience, where the mysteries of the human brain ...

Experts in the fields of brain health, Alzheimer’s disease, caregiving and legal and long-term planning will speak to ...

The root causes of most forms of Alzheimer's disease largely remain a mystery. Now, researchers have revealed a new piece of ...

Doug Whitney, a 75-yearold Navy veteran from Washington State, lost 10 members of his family to early-onset Alzheimer's ...

Using a new animal model of Alzheimer’s disease, the study highlights a potential breakthrough in treatment strategies.

More than 6 million Americans are diagnosed with Alzheimer's disease, a number expected to climb as the population ages.

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.” ...

Researchers have discovered a new type of neuron that plays a fundamental role in recognition memory -- how the brain registers the difference between new and familiar objects and forms long-term ...

Alpha-GPC, a choline-rich supplement, enhances brain health by increasing acetylcholine, with potential applications in ...